<i>De novo MAP2K4</i> variants cause a novel neurodevelopmental syndrome with impaired JNK signaling in iPSC-derived neurons
Tomoki Nomakuchi(Children's Hospital of Philadelphia), Elizabeth J. K. Bhoj(Children's Hospital of Philadelphia)
Cited by 0
Related Papers
Hyperinsulinism in an individual with an <scp><i>EP300</i></scp> variant of <scp>Rubinstein‐Taybi</scp> syndrome
|American Journal of Medical Genetics Part A|2021|5